Local hemostatic agents and ways of their improvement

Abstract

Recently, local hemostatic agents (LHA) have become increasingly popular abroad and in our country. They act in a targeted way and can be used both in damage to large vessels and in diffuse bleeding. In the article, chemical nature, physical and chemical characteristics of materials and mechanisms of LHA activity are considered, directions of their improvement are shown. LHA are mostly classified by mechanism of action.

To date, the popular groups of hemostatic agents are «mucoadhesive agents» (chitosan, amylopectin) and «coagulation factors concentrators» (zeolites, kaolin). Other authors distinguish the group of «aggregation and adhesion stimulants» (collagen, cellulose). Here, representatives of these groups have common characteristics – very high porosity and hydration ability. Another group includes substances that «promote protein denaturation» (inorganic salts of metals, as well as salts of acrylic acid and its derivatives). Polyacrylates are the basis of adhesives with hemostatic activity. However, most modern LHA are complex drugs and it is just this group that is most promising. All means, from hemostatic sponges produced by Zelyonaya Dubrava (Russia) and Nycomed, Takeda (Austria, Norway), and to hemostatic materials of MedTrade manufacture (Great Britain), Etiguette and Z-Medica (USA), combine sorption and, actually, thrombotic properties. The trademarks often imply original compositions and, especially, technologies: Quick Relief, BioSeal, BallistiClot, Hemaderm, CELOX Gauze PRO, OMNI-STAT Hemostatic Gauze for minor external bleeding. The most effective LHA are those based on chitosan and kaolin in the form of dressings with embedded clot-forming substance, for example, with artificial platelets or other coagulation factors.

Keywords

local hemostatic agents / hemostatic sponges / zeolites / chitosan / methylcellulose / collagen / gelatin

References

[1] Samokhvalov IM, Reva VA, Pronchenko AA, et al. Local hemostatic measures: the new era in delivery of prehospital aid. Polytrauma. 2013;(1):80-6. (In Russ).

[2] Самохвалов И.М., Рева В.А., Пронченко А.А., и др. Местные гемостатические средства: новая эра в оказании догоспитальной помощи // Политравма. 2013. №1. С. 80-86.

[3] Petlakh VI. Results of Use of Local Hemostatics in Disaster Medicine. Disaster Medicine. 2014;4(88): 21-4. (In Russ).

[4] Петлах В.И. Результаты применения местных гемостатиков в медицине катастроф // Медицина катастроф. 2014. №4 (88). С. 21-24.

[5] Galanakis I, Vasdev N, Soomro N. A Review of Current Hemostatic Agents and Tissue Sealants Used in Laparoscopic Partial Nephrectomy. Reviews in Urology. 2011;13(3):131-8. doi:10.3909/riu0524

[6] Galanakis I., Vasdev N., Soomro N. A Review of Current Hemostatic Agents and Tissue Sealants Used in Laparoscopic Partial Nephrectomy // Reviews in Urology. 2011. Vol. 13, №3. P. 131-138. doi:10.3909/riu0524

[7] Lutsevich OE, Grin AA, Bichev AA, et al. Features of the application of hemostatic material topical surgery. Moscow Surgical Journal. 2016;49(3):12-20. (In Russ).

[8] Луцевич О.Э., Гринь А.А., Бичев А.А., и др. Особенности применения гемостатических материалов местного действия в хирургии // Московский хирургический журнал. 2016. Т. 49, №3. С. 12-20.

[9] Kumar SMP. Local hemostatic agents in the mana-gement of bleeding in oral surgery. Asian Journal Pharmaceutical and Medical Research. 2016;9(3): 35-41.

[10] Kumar S.M.P. Local hemostatic agents in the management of bleeding in oral surgery // Asian Journal of Pharmaceutical and Medical Research. 2016. Vol. 9, №3. Р. 35-41.

[11] Achneck HE, Sileshi B, Jamiolkowski RM, et al. A Comprehensive Review of Topical Hemostatic Agents Efficacy and Recommendations for Use. Annals of Surgery. 2010;251(2):217-28. doi:10.1097/ SLA.0b013e3181c3bcca

[12] Achneck H.E., Sileshi B., Jamiolkowski R.M., et al. A Comprehensive Review of Topical Hemosta-tic Agents: Efficacy and Recommendations for Use // Annals of Surgery. 2010. Vol. 251, №2. P. 217-228. doi:10.1097/SLA.0b013e3181c3bcca

[13] Belozerskaya GG, Makarov VA, Zhidkov EA, et al. Local hemostatics (a review). Pharmaceutical Chemistry Journal. 2006;40(7):9-15. (In Russ). doi:10.30906/0023-1134-2006-40-7-9-15

[14] Белозерская Г.Г., Макаров В.А., Жидков Е.А., и др. Гемостатические средства местного действия (обзор) // Химико-фармацевтический журнал. 2006. Т. 40, №7. С. 9-15. doi:10.30906/0023-1134-2006-40-7-9-15

[15] Samokhvalov IM, Golovko KP, Reva VA, et al. Usage of local hemostatic agent «Celox» in experimental model of massive external bleeding. Vestnik Rossiyskoy Voyenno-Meditsinskoy Akademii. 2013;44(4):187-91. (In Russ).

[16] Самохвалов И.М., Головко К.П., Рева В.А., и др. Применение местного гемостатического средства «CELOX» в экспериментальной модели массивного смешанного наружного кровотечения // Вестник Российской военно-медицинской академии. 2013. Т. 44, №4. С. 187-191.

[17] Molchanova AA, Grinberg VB, Kushikov KT. Blood vessels in histological preparations. Herald ASIAME. 2018;(2):23-6. (In Russ).

[18] Молчанова А.А., Гринберг В.Б., Кушиков К.Т. Кровоостанавливающие средства в гистологических препаратах // Вестник АГИУВ. 2018. №2. С. 23-26.

[19] Bunatyan AG, Zavenyan ZS, Bagmet HH, et al. Problemy gemostaza i germetizma pri rezektsiyakh pecheni s ispol’zovaniyem fibrin-kollagenovoy substantsii. Khirurgiya. Zhurnal imeni N.I. Pirogova. 2003;(9):18-23. (In Russ).

[20] Бунатян А.Г., Завенян З.С., Багмет H.H., и др. Проблемы гемостаза и герметизма при резекциях печени с использованием фибрин-коллагеновой субстанции // Хирургия. Журнал им. Н.И. Пирогова. 2003. №9. С. 18-23.

[21] Istranov LP, Aboyants RK, Belozerskaya GG, et al. Collagen-based local hemostatics. Pharmacy. 2007; (7):29-32. (In Russ).

[22] Истранов Л.П., Абоянц Р.К., Белозерская Г.Г., и др. Местные гемостатические средства на основе коллагена // Фармация. 2007. №7. С. 29-32.

[23] Romantsov MN, Cherednikov EF, Danilenko VI, et al. Morphological Characteristics of Processes of Simulated Bleeding Gastric Defects Reparation in Treatment with Gelplastan and Diovin. Žurnal Anatomii i Gistopatologiii. 2017;6(1):81-6. (In Russ). doi:10.18499/2225-7357-2017-6-1-81-86

[24] Романцов М.Н., Чередников Е.Ф., Даниленко В.И., и др. Морфологическая характеристика процессов репарации моделированных кровоточащих дефектов желудка при лечении желпластаном и диовином // Журнал анатомии и гистопатологии. 2017. Т. 6, №1. С. 81-86. doi:10.18499/2225-7357-2017-6-1-81-86

[25] Skryabin KG, Vikhoreva GA, Varlamov VP. Khitin i khitozan. Polucheniye, svoystva i primeneniye. Moscow: Nauka; 2002. (In Russ).

[26] Скрябин К.Г., Вихорева Г.А., Варламов В.П. Хитин и хитозан. Получение, свойства и применение. М.: Наука; 2002.

[27] Chan LW, Kim ChH, Wang X, et al. PolySTAT-Modified Chitosan Gauzes for Improved Hemostasis in External Hemorrhage. Acta Biomaterialia. 2016;31:178-85. doi:10.1016/j.actbio.2015.11.017

[28] Chan L.W., Kim Ch.H., Wang X., et al. PolySTAT-Modified Chitosan Gauzes for Improved Hemostasis in External Hemorrhage // Acta Biomaterialia. 2016. Vol. 31. P. 178-185. doi:10.1016/j.actbio.2015.11.017

[29] Hu Zh, Ouyang QQ, Cheng Y, et al. Optimization of preparation process and characterization of carboxymethyl chitosan/sodium alginate hemostatic sponge. IOP Conference Series: Materials Science and Engineering. 2017;213:012045. doi:10.1088/ 1757-899X/213/1/012045

[30] Hu Zh., Ouyang Q.Q., Cheng Y., et al. Optimization of preparation process and characterization of carboxymethyl chitosan/sodium alginate hemostatic sponge // IOP Conference Series: Materials Science and Engineering. 2017. Vol. 213. P. 012045. doi:10.1088/1757-899X/213/1/012045

[31] Antisdel JL, West-Denning JL, Sindwani R. Effect of microporous polysaccharide hemospheres (MPH) on bleeding after endoscopic sinus surgery. Randomized controlled study. Otolaryngology – Head and Neck Surgery. 2009;141(3):353-7. doi:10.1016/ j.otohns.2009.06.078

[32] Antisdel J.L., West-Denning J.L., Sindwani R. Effect of microporous polysaccharide hemospheres (MPH) on bleeding after endoscopic sinus surgery. Randomized controlled study // Otolaryngology – Head and Neck Surgery. 2009. Vol. 141, №3. Р. 353-357. doi:10.1016/j.otohns.2009.06.078

[33] Achneck HE, Sileshi B, Jamiolkowski M, et al. A Comprehensive Review of Topical Hemostatic Agents. Annals of Surgery. 2009;251(2):217-28. doi:10.1097/SLA.0b013e3181c3bcca

[34] Achneck H.E., Sileshi B., Jamiolkowski M., et al. A Comprehensive Review of Topical Hemostatic Agents // Annals of Surgery. 2009. Vol. 251, №2. P. 217-228. doi:10.1097/SLA.0b013e3181c3bcca

[35] Plotkin AV, Pokrovskij EZh, Voronova GV, et al. The evaluation of the effectivity of hemostatic activity of Haemoblock for local topical use Haemoblock in different surgical situations. Multicenter clinical trials. Vestnik Sovremennoi Klinicheskoi Mediciny. 2015;8(1):56-61. (In Russ).

[36] Плоткин А.В., Покровский Е.Ж., Воронова Г.В., и др. Оценка эффективности гемостатического действия препарата «гемоблок» при полостных и лапароскопических вмешательствах. Мультицентровые клинические исследования // Вестник современной клинической медицины. 2015. Т. 8, №1. С. 56-61.

[37] Chan LW, Wang X, Wei H, et al. A Synthetic Fibrin-Crosslinking Polymer for Modulating Clot Properties and Inducing Hemostasis. Science Translational Medicine. 2015;7(277):1-11. doi:10.1126/ scitranslmed.3010383

[38] Chan L.W., Wang X., Wei H., et al. A Synthetic Fibrin-Crosslinking Polymer for Modulating Clot Properties and Inducing Hemostasis // Science Translational Medicine. 2015. Vol. 7, №277. P. 1-11. doi:10.1126/scitranslmed.3010383

[39] Travers S, Lefort H, Ramdani E, et al. Hemostatic dressings in civil prehospital practice: 30 uses of QuikClot Combat Gauze. European Journal of Emergency Medicine. 2016;23(5):391-4. doi:10.1097/ MEJ.0000000000000318

[40] Travers S., Lefort H., Ramdani E., et al. Hemostatic dressings in civil prehospital practice: 30 uses of QuikClot Combat Gauze // European Journal of Emergency Medicine. 2016. Vol. 23, №5. P. 391-394. doi:10.1097/MEJ.0000000000000318

RIGHTS & PERMISSIONS

Budko E.V., Chernikova D.A., Yampolsky L.M., Yatsyuk V.Y.